COLL Collegium Pharmaceutical, Inc.

NASDAQ
$25.21

Collegium Pharmaceutical, Inc. (COLL) Earnings News

Earnings press releases, previews and reviews for Collegium Pharmaceutical, Inc. (COLL), newest first. Our most recent is review: Collegium Beats on ADHD Strength, but Pain Erosion and Heavier Spending Keep Earnings Shrinking.